160 related articles for article (PubMed ID: 4154022)
1. Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cells.
Bortin MM; Rimm AA; Rose WC; Saltzstein EC
Transplantation; 1974 Sep; 18(3):280-3. PubMed ID: 4154022
[No Abstract] [Full Text] [Related]
2. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
[No Abstract] [Full Text] [Related]
3. An investigation into the influence of a graft-versus-host reaction, induced by parent line cells, on the growth of lymphoma transplants in F1 hybrid mice.
Palmer AM; Symes MO
Folia Biol (Praha); 1974; 20(1):26-35. PubMed ID: 4154872
[No Abstract] [Full Text] [Related]
4. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy.
Saltzstein EC; Glasspiegel JS; Rimm AA; Giller RH; Bortin MM
Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951
[No Abstract] [Full Text] [Related]
5. Time pattern of the antileukemic effect of graft-versus-host reaction in mice.
Boranić M; Tonković I
Cancer Res; 1971 Aug; 31(8):1140-7. PubMed ID: 4398523
[No Abstract] [Full Text] [Related]
6. Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma.
Truitt RL; Rimm AA; Saltzstein EC; Rose WC; Bortin MM
Transplant Proc; 1976 Dec; 8(4):569-74. PubMed ID: 11589
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms involved in the antileukemic effect of immunocompetent allogeneic lymphoid cell transfer.
Ellman L; Katz DH; Green I; Paul WE; Benacerraf B
Cancer Res; 1972 Jan; 32(1):141-8. PubMed ID: 4400015
[No Abstract] [Full Text] [Related]
8. Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice.
Chester SJ; Esparza AR; Flinton LJ; Simon JD; Kelley RJ; Albala MM
Cancer Res; 1977 Oct; 37(10):3494-6. PubMed ID: 20223
[TBL] [Abstract][Full Text] [Related]
9. Resistance of guinea pigs to leukemia following transfer of immunocompetent allogeneic lymphoid cells.
Katz DH; Ellman L; Paul WE; Green I; Benacerraf B
Cancer Res; 1972 Jan; 32(1):133-40. PubMed ID: 4400014
[No Abstract] [Full Text] [Related]
10. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
Chester SJ; Esparza AR; Albala MM
Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
[TBL] [Abstract][Full Text] [Related]
11. Graft-versus-leukemia effect in allogeneic bone marrow transplantation in mice against several radiation-induced leukemias.
Aizawa S; Sado T; Kamisaku H; Nemoto K; Yoshida K
Bone Marrow Transplant; 1994 Feb; 13(2):109-14. PubMed ID: 8205078
[TBL] [Abstract][Full Text] [Related]
12. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
Johnson BD; Drobyski WR; Truitt RL
Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetic disparity and graft-versus-host reactions.
Bach ML; Bach FH
Semin Hematol; 1974 Jul; 11(3):291-303. PubMed ID: 4151845
[No Abstract] [Full Text] [Related]
14. An MHC-compatible allogeneic bone marrow donor with a distinct role of T cell subsets in graft-versus-leukemia effect and lethal graft-versus-host disease.
Aizawa S; Kamisaku H; Sado T
Bone Marrow Transplant; 1995 Oct; 16(4):603-9. PubMed ID: 8528179
[TBL] [Abstract][Full Text] [Related]
15. Prolonged survival of AKR mice following allogeneic bone marrow transplantation.
Rose WC; Bortin MM; Saltzstein EC
Experientia; 1974 Sep; 30(9):1085-6. PubMed ID: 4153447
[No Abstract] [Full Text] [Related]
16. Immunocompetent cell functions in mice infected with Friend leukemia virus.
Bennett M; Steeves RA
J Natl Cancer Inst; 1970 May; 44(5):1107-19. PubMed ID: 4398242
[No Abstract] [Full Text] [Related]
17. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation.
Zeis M; Uharek L; Glass B; Vosskötter W; Dreger P; Schmitz N; Steinmann J
Exp Hematol; 1998 Oct; 26(11):1068-73. PubMed ID: 9766447
[TBL] [Abstract][Full Text] [Related]
18. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide.
Truitt RL; Rose WC; Rimm AA; Bortin MM
Exp Hematol; 1978 May; 6(5):488-98. PubMed ID: 26584
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-host reactions in mice. I. Kinetic and immunogenetic studies of alloantigen-sensitive units of lymphoid tissue.
Bennett M
Transplantation; 1971 Feb; 11(2):158-69. PubMed ID: 4397088
[No Abstract] [Full Text] [Related]
20. Transient graft-versus-host reaction in the treatment of leukemia in mice.
Boranić M
J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445
[No Abstract] [Full Text] [Related]
[Next] [New Search]
